Decentralized Clinical Trials Market 2026–2030: Factors Driving Growth, Demand, And Revenue Expansion

 

What Are The Estimated Market Size And CAGR For The Decentralized Clinical Trials Market Between 2026 And 2030?
 The decentralized clinical trials market size has grown rapidly in recent years. It will grow from $8.77 billion in 2025 to $10.31 billion in 2026 at a compound annual growth rate (CAGR) of 17.7%. The growth in the historic period can be attributed to increasing complexity of clinical trials, rising need for patient recruitment efficiency, expansion of digital health technologies, growing use of electronic data capture systems, increasing regulatory openness to decentralized models.
 
 The decentralized clinical trials market size is expected to see rapid growth in the next few years. It will grow to $19.55 billion in 2030 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to increasing adoption of hybrid trial designs, rising demand for faster drug development timelines, expansion of global virtual trials, growing use of ai-driven trial optimization, increasing focus on diverse patient participation. Major trends in the forecast period include increasing adoption of remote patient monitoring tools, growing use of virtual trial platforms, expansion of wearable-based data collection, rising implementation of real-time trial analytics, enhanced focus on patient-centric trial design.
 
 Claim Your Free Report Sample Today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=28189&type=smp
 
 Which Drivers Are Expected To Support The Future Advancement Of The Decentralized Clinical Trials Market?
 The rising focus on telemedicine is expected to propel growth in the decentralized clinical trials market going forward. Telemedicine is the delivery of healthcare services remotely through digital communication technologies, enabling medical consultations and monitoring without requiring physical presence at healthcare facilities. The growing focus on telemedicine is primarily driven by the need for accessible healthcare delivery in response to global health challenges and social distancing requirements. Decentralized clinical trials use telemedicine to remotely engage and monitor patients, minimizing in-person visits while enabling real-time data collection, greater access, and continuous oversight. For instance, in September 2024, according to the Australian Bureau of Statistics (ABS), the national statistical agency of Australia, in 2023–24, 83.5% of males reported using telehealth services, an increase from 78.6% in 2022–23. Therefore, rising focus on telemedicine is driving the growth of the decentralized clinical trials market.
 
 Which Segment Categories Are Influencing The Growth Trajectory Of The Decentralized Clinical Trials Market?
 The decentralized clinical trials market covered in this report is segmented — 
 
 1) By Type: Interventional, Observational, Expanded Access
 2) By Technology Used: Wearable Devices, Mobile Health Applications, Telemedicine Platforms, Electronic Data Capture Systems
 3) By Study Phase: Phase I, Phase II, Phase III, Phase IV
 4) By Therapeutic Area: Oncology, Cardiology, Neurology, Infectious Diseases
 5) By End-User: Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations, Regulatory Authorities, Academic And Research Institutions
 
 Subsegments:
 1) By Interventional: Randomized Controlled Trials (RCTs), Non-Randomized Trials, Adaptive Clinical Trials, Pragmatic Clinical Trials
 2) By Observational: Cohort Studies, Case-Control Studies, Cross-Sectional Studies, Prospective Studies, Retrospective Studies, Longitudinal Studies
 3) By Expanded Access: Treatment Investigational New Drug (IND) Applications, Intermediate-Size Patient Population Investigational New Drug (IND) Applications, Single-Patient Investigational New Drug (IND) Applications, Emergency Use Investigational New Drug (IND) Applications
 
 What Trends Are Driving Change Across The Decentralized Clinical Trials Market Landscape?
 Major companies operating in the decentralized clinical trials market are focusing on developing advanced solutions such as all-in-one, no-code clinical trials software to simplify trial setup and management and enhance overall efficiency and patient engagement. An all-in-one, no-code clinical trials software empowers researchers to design, manage, and run trials without coding while seamlessly integrating patient recruitment, data capture, monitoring, and analytics into a single user-friendly platform. For instance, in August 2024, Medable, a US-based clinical technology company, launched Medable Studio, an all-in-one, no-code software solution designed to simplify and accelerate the configuration, translation, validation, and launch of electronic Clinical Outcome Assessments (eCOA), eConsent, Televisit, and sensors Plus into clinical trials. It enables biopharmaceutical companies to create protocol-fit study designs in hours instead of months, giving users greater control, transparency, and speed, while offering flexible self-service, full-service, or hybrid options that significantly reduce study startup timelines and costs. This platform aims to revolutionize trial execution by making the study build process faster, more efficient, and less dependent on professional services.
 
 Which Organizations Are Considered Principal Leaders In The Decentralized Clinical Trials Market?
 Major companies operating in the decentralized clinical trials market are Walgreens Boots Alliance Inc., Pfizer Inc., Oracle Corporation, Thermo Fisher Scientific Inc., IQVIA Holdings Inc., Labcorp Holdings Inc., ICON Public Limited Company, Dassault Systèmes SE, LEO Pharma A/S, Verily Life Sciences LLC, ProPharma, Signant Health Holding Corp., PCM Trials, Huma Therapeutics Limited, Medable Inc., Science 37 Inc., Obvio Health, EmVenio Research Inc., Grove AI Inc., Phesi Inc. 
 
 Get Your In-Depth Decentralized Clinical Trials Market Report Now:
 https://www.thebusinessresearchcompany.com/report/decentralized-clinical-trials-global-market-report
 
 Which Geographical Areas Are Expected To Witness The Most Substantial Decentralized Clinical Trials Market Expansion Ahead?
 North America was the largest region in the decentralized clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the decentralized clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company